Fresenius SE & Co KGaA 2023 AR2
The report highlights Fresenius' strategic realignment under the #FutureFresenius program, focusing on its Operating Companies, Fresenius Kabi and Fresenius Helios, and the deconsolidation of Fresenius Medical Care. In fiscal year 2023, the company achieved organic revenue growth of 6% and a 2% increase in EBIT in constant currency. On sustainability, Fresenius made progress toward its climate targets, reducing Scope 1 and Scope 2 emissions by 22% compared to the 2020 baseline. Additionally, the company successfully implemented quantitative ESG key performance indicators into its Management Board compensation system.
Company: Fresenius SE & Co KGaA
Sector: Manufacturing
Country: Germany
Year: 2023
Type: AR2
Pages: 381
Fresenius SE & Co KGaA
The report highlights Fresenius' strategic realignment under the #FutureFresenius program, focusing on its Operating Companies, Fresenius Kabi and Fresenius Helios, and the deconsolidation of Fresenius Medical Care. In fiscal year 2023, the company achieved organic revenue growth of 6% and a 2% increase in EBIT in constant currency. On sustainability, Fresenius made progress toward its climate targets, reducing Scope 1 and Scope 2 emissions by 22% compared to the 2020 baseline. Additionally, the company successfully implemented quantitative ESG key performance indicators into its Management Board compensation system.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees